Sarepta Therapeutics Files 2024 10-K
Ticker: SRPT · Form: 10-K · Filed: Feb 28, 2025 · CIK: 873303
Sentiment: neutral
Topics: 10-K, annual-report, biotech
TL;DR
SRPT filed its 2024 10-K. Full financial picture inside.
AI Summary
Sarepta Therapeutics, Inc. filed its 2024 10-K on February 28, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is headquartered in Cambridge, MA. Key financial details and operational highlights for the period are detailed within the filing.
Why It Matters
This filing provides investors and the public with a comprehensive overview of Sarepta's financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Sarepta Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-28 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Sarepta Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-28 (date) — Filing date
- Cambridge, MA (location) — Company headquarters
- Michael A. Chambers (person) — Mentioned in relation to stock units
- University of Western Australia (company) — Mentioned in relation to a date
FAQ
What was Sarepta Therapeutics' primary business focus as indicated in the filing?
Sarepta Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When did Sarepta Therapeutics' fiscal year 2024 end?
The fiscal year end for Sarepta Therapeutics, Inc. in this filing was December 31, 2024.
On what date was this 10-K filing submitted?
This 10-K filing was submitted on February 28, 2025.
Where is Sarepta Therapeutics, Inc. headquartered?
Sarepta Therapeutics, Inc. is headquartered in Cambridge, MA, with a business and mailing address at 215 First Street, Suite 415.
What are some of the specific entities or individuals mentioned in relation to dates or stock units?
The filing mentions Michael A. Chambers in relation to 'StockUnitsWithServiceConditions' as of 2024-12-31, and the University of Western Australia in relation to the date 2022-12-31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 by Michael A. Chambers regarding Sarepta Therapeutics, Inc. (SRPT).